Global Healthcare Cloud Based Analytics Market size is expected to be worth around USD 223.5 Billion by 2033 from USD 38.6 ...

Global Healthcare Supply Chain Outsourcing Market size is expected to be worth around USD 5.4 Billion by 2033 from USD 3.1 ...

Intelligence report sounds alarm on Putin’s plan to control US society Snakehead fish pulls off gravity-defying leap over river obstacle Chris Pratt says son 'fighting for his life' led him to devote ...

Ruben Amorim deviated from his trusted 3-4-3 for the first time as Manchester United manager as he experimented with a new-look system for the Premier League match against Bournemouth. At first glance ...

Formation Bio is inking a deal worth more than $600 million in biobucks for ex-China rights to a next-gen immunology asset from Lynk Pharmaceuticals. Lynk’s program will be developed by Formation’s ...

Artificial intelligence accounting automation platform startup Numeric has raised $51 million in new funding to expand from close management into a broader compound startup model that delivers a ...

Jean-Charles Pelland's work has been made possible by financial support from the ‘QUANTA: Evolution of Cognitive Tools for Quantification’ project, which has received funding from the European ...

Grand Collection showcases their reimagined 770 sneaker on the runway and in a feature skate film following an extensive rollout with a gallery in Paris Fashion Week, and an off-calendar runway show.

The 1990s era continues to be a major inspiration for sneaker brands around the world, as New Balance has reintroduced and reclassified a cross-trainer from the past. New Balance's Numeric category ...

1 Department of Sustainable Natural Resources, Botswana International University of Science and Technology, Palapye, Botswana 2 Division of Soil Science and Geoecology, Institute of Environmental ...

The star of Monday’s deal is gusacitinib, a small-molecule drug that Formation is developing for chronic hand eczema. Sanofi will explore additional indications for gusacitinib in a Phase I study.